Skip to Content

PAN 5 (Pancrelipase Delayed-Release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease)

Pill with imprint PAN 5 is White, Capsule-shape and has been identified as Pancrelipase Delayed-Release 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease. It is supplied by X-GEN Pharmaceuticals, Inc..

Pancrelipase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancrelipase 16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAN 5

Pancrelipase Delayed-Release

Imprint:
PAN 5
Strength:
16,000 units amylase / 3,000 USP units lipase / 10,000 USP units protease
Color:
White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
X-GEN Pharmaceuticals, Inc.
National Drug Code (NDC):
39822-0205

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide